लोड हो रहा है...

Producing recombinant therapeutic glycoproteins with enhanced sialylation using CHO-gmt4 glycosylation mutant cells

Recombinant glycoprotein drugs require proper glycosylation for optimal therapeutic efficacy. Glycoprotein therapeutics are rapidly removed from circulation and have reduced efficacy if they are poorly sialylated. Ricinus communis agglutinin-I (RCA-I) was found highly toxic to wild-type CHO-K1 cells...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Goh, John SY, Liu, Yingwei, Chan, Kah Fai, Wan, Corrine, Teo, Gavin, Zhang, Peiqing, Zhang, Yuanxing, Song, Zhiwei
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Landes Bioscience 2014
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4143398/
https://ncbi.nlm.nih.gov/pubmed/24911584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/bioe.29490
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!